找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Management of Pancreatic Cancer and Cholangiocarcinoma; Hiroyuki Isayama,Yousuke Nakai,Takashi Sasaki Book 2021 The Editor(s) (if applicab

[复制链接]
查看: 19661|回复: 53
发表于 2025-3-21 19:42:08 | 显示全部楼层 |阅读模式
书目名称Management of Pancreatic Cancer and Cholangiocarcinoma
编辑Hiroyuki Isayama,Yousuke Nakai,Takashi Sasaki
视频video
概述Covers recent topics in epidemiology, examination, treatment and endoscopic management of pancreatobiliary malignancies.Will appeal to surgeons, endoscopists and oncologists.Explores risk factors and
图书封面Titlebook: Management of Pancreatic Cancer and Cholangiocarcinoma;  Hiroyuki Isayama,Yousuke Nakai,Takashi Sasaki Book 2021 The Editor(s) (if applicab
描述.This comprehensive book presents the latest evidence-based data on pancreatobiliary malignancies, including the epidemiology, examination, treatment and endoscopic management. It explores a range of topics, such as risk factors, detection strategies, and novel treatment approaches like precision medicine and immunotherapy..Although there have been rapid improvements in the management of these diseases, the survival period has not yet reached a satisfactory level. This book will help those doctors needing to share the latest information with the patients and their families. It provides a wealth of practical information to help surgeons, endoscopists and oncologists as well as physicians, basic researchers and professionals at medical device and pharmaceutical companies broaden their understanding of the current treatment and management strategies for pancreatobiliary malignancies..
出版日期Book 2021
关键词Pancreas Cancer; Bile Duct Cancer; Cholangiocarcinoma; Surgery; Endoscopic Treatment; Interventional EUS;
版次1
doihttps://doi.org/10.1007/978-981-16-2870-2
isbn_softcover978-981-16-2872-6
isbn_ebook978-981-16-2870-2
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapor
The information of publication is updating

书目名称Management of Pancreatic Cancer and Cholangiocarcinoma影响因子(影响力)




书目名称Management of Pancreatic Cancer and Cholangiocarcinoma影响因子(影响力)学科排名




书目名称Management of Pancreatic Cancer and Cholangiocarcinoma网络公开度




书目名称Management of Pancreatic Cancer and Cholangiocarcinoma网络公开度学科排名




书目名称Management of Pancreatic Cancer and Cholangiocarcinoma被引频次




书目名称Management of Pancreatic Cancer and Cholangiocarcinoma被引频次学科排名




书目名称Management of Pancreatic Cancer and Cholangiocarcinoma年度引用




书目名称Management of Pancreatic Cancer and Cholangiocarcinoma年度引用学科排名




书目名称Management of Pancreatic Cancer and Cholangiocarcinoma读者反馈




书目名称Management of Pancreatic Cancer and Cholangiocarcinoma读者反馈学科排名




单选投票, 共有 1 人参与投票
 

1票 100.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 22:45:44 | 显示全部楼层
Book 2021and endoscopic management. It explores a range of topics, such as risk factors, detection strategies, and novel treatment approaches like precision medicine and immunotherapy..Although there have been rapid improvements in the management of these diseases, the survival period has not yet reached a s
发表于 2025-3-22 03:44:42 | 显示全部楼层
发表于 2025-3-22 05:53:47 | 显示全部楼层
发表于 2025-3-22 10:40:35 | 显示全部楼层
发表于 2025-3-22 13:08:02 | 显示全部楼层
发表于 2025-3-22 18:51:00 | 显示全部楼层
发表于 2025-3-22 22:11:03 | 显示全部楼层
Radiotherapy for Pancreatic Cancern. The life-prolonging effect of radiotherapy has not yet been clearly demonstrated, but it has been shown to lead to improved local control. In this chapter, we will introduce radiotherapy for pancreatic cancer, focusing on the heavy-ion radiotherapy that we are performing.
发表于 2025-3-23 05:19:42 | 显示全部楼层
Conversion Surgery in Pancreatic Cancerthere are no robust data which indicate the clear benefit of CS and no consensus of the indication and optimal timing of CS for initially unresectable pancreatic cancer. Several prospective clinical trials are ongoing to clarify the benefit of CS for UR-PDAC.
发表于 2025-3-23 09:11:43 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-19 11:46
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表